GENVEC
GenVec, Inc. (NASDAQ: GNVC) GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant hum... an and animal health concerns. GenVec’s development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD).
GENVEC
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1992-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.genvec.com
Total Employee:
11+
Status:
Active
Contact:
3019441894
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
JQuery CDN DigiCert SSL Apple Whitelist
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AscentGene
AscentGene specializes in cell lines services, protein & enzymes research, gene function studies & monoclonal antibody production solutions.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Peptinovo Biopharma
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - GenVec
